We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemodynamic Measurements in Women With Serious Preeclampsia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00199810
First Posted: September 20, 2005
Last Update Posted: October 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Eldrid Langesæter, Oslo University Hospital
  Purpose
This trial is examining hemodynamic measurements in women with serious preeclampsia.

Condition Phase
Preeclampsia Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hemodynamic Measurements in Women With Serious Preeclampsia

Resource links provided by NLM:


Further study details as provided by Eldrid Langesæter, Oslo University Hospital:

Primary Outcome Measures:
  • Hemodynamic variations in preeclamptic women [ Time Frame: days ]

Secondary Outcome Measures:
  • Urine output [ Time Frame: days ]
  • thrombocyte count [ Time Frame: days ]

Enrollment: 68
Study Start Date: July 2005
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women with moderate-to-severe pre-eclampsia
Criteria

Inclusion Criteria:

  • Women with serious preeclampsia
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00199810


Locations
Norway
Oslo University Hospital
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
Investigators
Principal Investigator: Eldrid Langesæter Langesæter Oslo University Hospital
  More Information

Responsible Party: Eldrid Langesæter, Consultant, MD, PhD, Oslo University Hospital
ClinicalTrials.gov Identifier: NCT00199810     History of Changes
Other Study ID Numbers: Elangepreeklampsi2005-
S-05173
First Submitted: September 15, 2005
First Posted: September 20, 2005
Last Update Posted: October 17, 2016
Last Verified: October 2016

Keywords provided by Eldrid Langesæter, Oslo University Hospital:
Cardiac output
Preeclamptic women
systemic vascular resistance
blood pressure

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications